	US 11,752,119 B2
	Administration of beta-hydroxybutyrate and related compounds in humans for the treatment and/or prevention of respiratory illnesses
Ryan Lowery, Tampa, FL (US); and Jacob Wilson, Tampa, FL (US)
Assigned to AXCESS GLOBAL SCIENCES, LLC, Salt Lake City, UT (US)
Filed by AXCESS GLOBAL SCIENCES, LLC, Salt Lake City, UT (US)
Filed on Jul. 23, 2021, as Appl. No. 17/384,632.
Claims priority of provisional application 63/055,798, filed on Jul. 23, 2020.
Prior Publication US 2022/0023242 A1, Jan. 27, 2022
Int. Cl. A61K 31/19 (2006.01); A61P 31/14 (2006.01); A61K 9/00 (2006.01)

CPC A61K 31/19 (2013.01) [A61K 9/0053 (2013.01); A61P 31/14 (2018.01)]

20 Claims

1. A method of improving one or more respiratory illnesses in an individual, the method comprising:

orally administering, to an individual, a pharmaceutically effective amount of a composition comprising:

approximately 0.5 g to approximately 10 g of R-beta-hydroxybutyrate, wherein the R-beta-hydroxybutyrate comprises at least one R-beta-hydroxybutyrate salt; and

wherein the administration of the composition improves respiratory illnesses in an individual.